Oncotelic Therapeutics, Inc.
PublicOncotelic Therapeutics, Inc. is now publicly traded
The data on this page reflects Oncotelic Therapeutics, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Grant
Jul 22, 2026
Total Funding Raised
$711,840
Company Overview
Oncotelic Therapeutics, Inc. is a biopharmaceutical company that develops RNA-based, immunotherapy, and targeted therapeutics for the treatment of cancer and other rare diseases.
Sector
Healthcare
AI Layer
Non-AI
Keywords
Oncotelic Therapeutics, Inc. Comparables
Compare Oncotelic Therapeutics, Inc. with similar companies based on industry and business-model similarity.
No public comparables are available for Oncotelic Therapeutics, Inc.. Request access to learn about comparables coverage.
Request accessOncotelic Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 22, 2026 |
Recent news
Latest coverage and updates
- partners_withJun 29, 2026
Oncotelic Inc. partnered with Sapu Nano on Jun 29th '26.
Oncotelic Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access